Medical devices, healthcare technology and the business of care
510(k) clearance · K260597

VIRTUE QA

ProNova Solutions · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONK260597

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for VIRTUE QA, a ProNova Solutions software-only device, on September 23, 2026, under 510(k) K260597. The submission falls under 21 CFR 892.5050 (Medical Charged-Particle Radiation Therapy System), Class II, product code LHN, in the radiology specialty. The public database lists the date received as February 24, 2026, while the clearance letter cites a dated August 17, 2026 and received August 18, 2026; the source does not reconcile the discrepancy.

The 510(k) summary describes four analysis modules plus offline image review, and names myQA iON (K201798) as predicate with Mobius3D (K153014) as reference device supporting CBCT-to-planning-CT registration. The comparison table labels pre-treatment predictive QA as a new capability and offline image review as supported by the reference device. The database page notes a Predetermined Change Control Plan authorized, and the summary contents list modifications for daily model retraining and additional proton vendor platforms; the supplied excerpts do not give their authorized scope.

The indications state the device is not a treatment planning system and does not control treatment delivery. No clinical performance data, patient-selection criteria, or independent efficacy findings appear in the supplied excerpts, so those remain unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260597
Regulatory pathway
510(k) premarket notification
Product code
LHN
Decision code
SESE
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Radiation Therapy, Charged-Particle, Medical.

Product code
LHN
FDA device class
2

FDA decision timeline

  1. K260597 received

    Application receipt date recorded by FDA.

  2. K260597 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ProNova Solutions

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Maryville, TN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records